Skip to content

It looks like we may have content for your preferred language. Would you like to view this page in English?

IPO of AzurRx BioPharma, Inc.

Represented AzurRx BioPharma, Inc., a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, in its initial public offering and NASDAQ listing.